Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE USP, with a corresponding US DMF Number 20769.
Remarkably, this DMF maintains an Active status since its submission on August 10, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2014, and payment made on April 04, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II